Glucose is a key regulator of VEGFR2/KDR in human epithelial ovarian carcinoma cells

Biochemical and Biophysical Research Communications

Volumn 390, Issue 1, 2009, Pages 130-135

  Adham, Sirin A I ^a   Coomber, Brenda L ^a  

^a UNIVERSITY OF GUELPH   (Canada)

Author keywords

Angiogenesis factors; Hypoglycaemia; Ovarian cancer; VEGFR2

Indexed keywords

GLUCOSE; MESSENGER RNA; NEUROPILIN 1; VASCULOTROPIN RECEPTOR 2;

ARTICLE; CARCINOMA CELL; CELL CYCLE PROGRESSION; ENDOPLASMIC RETICULUM; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIUM CELL; FEEDBACK SYSTEM; GLYCOSYLATION; HUMAN; HUMAN CELL; METABOLISM; OVARY CARCINOMA; OVARY CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ISOLATION; PROTEIN SECRETION; PROTEIN SYNTHESIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING;

CARCINOMA; CELL LINE, TUMOR; FEMALE; GLUCOSE; GLYCOSYLATION; HUMANS; HYPERGLYCEMIA; NEUROPILIN-1; OVARIAN NEOPLASMS; PROTEASOME ENDOPEPTIDASE COMPLEX; RNA, MESSENGER; TRANSCRIPTION, GENETIC; TRANSCRIPTIONAL ACTIVATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 70349937895     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2009.09.081     Document Type: Article

References (21)

1. Landen Jr. C.N., Birrer M.J., and Sood A.K. Early events in the pathogenesis of epithelial ovarian cancer. J. Clin. Oncol. 26 (2008) 995-1005
2. Boocock C.A., Charnock-Jones D.S., Sharkey A.M., McLaren J., Barker P.J., Wright K.A., Twentyman P.R., and Smith S.K. Expression of vascular endothelial growth factor and its receptors flt and KDR in ovarian carcinoma. J. Natl. Cancer Inst. 87 (1995) 506-516
3. Hu Y.L., Tee M.K., Goetzl E.J., Auersperg N., Mills G.B., Ferrara N., and Jaffe R.B. Lysophosphatidic acid induction of vascular endothelial growth factor expression in human ovarian cancer cells. J. Natl. Cancer Inst. 93 (2001) 762-768
4. Satake S., Kuzuya M., Miura H., Asai T., Ramos M.A., Muraguchi M., Ohmoto Y., and Iguchi A. Up-regulation of vascular endothelial growth factor in response to glucose deprivation. Biol. Cell 90 (1998) 161-168
5. Zhang L., Conejo-Garcia J.R., Yang N., Huang W., Mohamed-Hadley A., Yao W., Benencia F., and Coukos G. Different effects of glucose starvation on expression and stability of VEGF mRNA isoforms in murine ovarian cancer cells. Biochem. Biophys. Res. Commun. 292 (2002) 860-868
6. Shahrzad S., Quayle L., Stone C., Plumb C., Shirasawa S., Rak J.W., and Coomber B.L. Ischemia-induced K-ras mutations in human colorectal cancer cells: Role of microenvironmental regulation of MSH2 expression. Cancer Res. 65 (2005) 8134-8141
7. Stein I., Neeman M., Shweiki D., Itin A., and Keshet E. Stabilization of vascular endothelial growth factor mRNA by hypoxia and hypoglycemia and coregulation with other ischemia-induced genes. Mol. Cell. Biol. 15 (1995) 5363-5368
8. Kurokawa T., Yoshida Y., Kawahara K., Tsuchida T., Okazawa H., Fujibayashi Y., Yonekura Y., and Kotsuji F. Expression of GLUT-1 glucose transfer, cellular proliferation activity and grade of tumor correlate with [F-18]-fluorodeoxyglucose uptake by positron emission tomography in epithelial tumors of the ovary. Int. J. Cancer 109 (2004) 926-932
9. Yeung B.H., Kwan B.W., He Q.Y., Lee A.S., Liu J., and Wong A.S. Glucose-regulated protein 78 as a novel effector of BRCA1 for inhibiting stress-induced apoptosis. Oncogene 27 (2008) 6782-6789
10. Saito S., Furuno A., Sakurai J., Sakamoto A., Park H.R., Shin-Ya K., Tsuruo T., and Tomida A. Chemical genomics identifies the unfolded protein response as a target for selective cancer cell killing during glucose deprivation. Cancer Res. 69 (2009) 4225-4234
11. Mulholland H.G., Murray L.J., Cardwell C.R., and Cantwell M.M. Dietary glycaemic index, glycaemic load and endometrial and ovarian cancer risk: a systematic review and meta-analysis. Br. J. Cancer 99 (2008) 434-441
12. Fiedler J., Leucht F., Waltenberger J., Dehio C., and Brenner R.E. VEGF-A and PlGF-1 stimulate chemotactic migration of human mesenchymal progenitor cells. Biochem. Biophys. Res. Commun. 334 (2005) 561-568
13. Sher I., Adham S.A., Petrik J., and Coomber B.L. Autocrine VEGF-A/KDR loop protects epithelial ovarian carcinoma cells from anoikis. Int. J. Cancer 124 (2009) 553-561
14. Terman B.I., Dougher-Vermazen M., Carrion M.E., Dimitrov D., Armellino D.C., Gospodarowicz D., and Bohlen P. Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor. Biochem. Biophys. Res. Commun. 187 (1992) 1579-1586
15. Takahashi T., and Shibuya M. The 230 kDa mature form of KDR/Flk-1 (VEGF receptor-2) activates the PLC-gamma pathway and partially induces mitotic signals in NIH3T3 fibroblasts. Oncogene 14 (1997) 2079-2089
16. Mesiano S., Ferrara N., and Jaffe R.B. Role of vascular endothelial growth factor in ovarian cancer: Inhibition of ascites formation by immunoneutralization. Am. J. Pathol. 153 (1998) 1249-1256
17. Shintani Y., Takashima S., Asano Y., Kato H., Liao Y., Yamazaki S., Tsukamoto O., Seguchi O., Yamamoto H., Fukushima T., Sugahara K., Kitakaze M., and Hori M. Glycosaminoglycan modification of neuropilin-1 modulates VEGFR2 signaling. EMBO J. 25 (2006) 3045-3055
18. Kou R., SenBanerjee S., Jain M.K., and Michel T. Differential regulation of vascular endothelial growth factor receptors (VEGFR) revealed by RNA interference: Interactions of VEGFR-1 and VEGFR-2 in endothelial cell signaling. Biochemistry 44 (2005) 15064-15073
19. Chiarelli F., Spagnoli A., Basciani F., Tumini S., Mezzetti A., Cipollone F., Cuccurullo F., Morgese G., and Verrotti A. Vascular endothelial growth factor (VEGF) in children, adolescents and young adults with type 1 diabetes mellitus: Relation to glycaemic control and microvascular complications. Diabet. Med. 17 (2000) 650-656
20. Bazzaro M., Lee M.K., Zoso A., Stirling W.L., Santillan A., Shih I., and Roden R.B. Ubiquitin-proteasome system stress sensitizes ovarian cancer to proteasome inhibitor-induced apoptosis. Cancer Res. 66 (2006) 3754-3763
21. Haze K., Yoshida H., Yanagi H., Yura T., and Mori K. Mammalian transcription factor ATF6 is synthesized as a transmembrane protein and activated by proteolysis in response to endoplasmic reticulum stress. Mol. Biol. Cell 10 (1999) 3787-3799